GlaxoSmithKline Pharmaceuticals reports 4% fall in Q3 consolidated net profit

08 Feb 2022 Evaluate

GlaxoSmithKline Pharmaceuticals has reported results for third quarter ended December 31, 2021.

The company has reported a fall of 4.91% in its net profit at Rs 149.63 crore for the quarter under review as compared to Rs 157.35 crore for the same quarter in the previous year. However, total income of the company marginally increased by 1.43% at Rs 818.48 crore for Q3FY22 as compared Rs 806.96 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a fall of 3.94% in its net profit at Rs 150.35 crore for the quarter under review as compared to Rs 156.51 crore for the same quarter in the previous year. However, total income of the company increased by 2.53% at Rs 826.24 crore for Q3FY22 as compared Rs 805.89 crore for the corresponding quarter previous year.

Glaxosmithkline Phar Share Price

2476.65 11.75 (0.48%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×